Autologous Bone Marrow-derived Mononuclear Cells for Therapeutic Arteriogenesis in Patients With Limb Ischemia

Clinical trial NCT00539266 · UNKNOWN

Trial details

NCT number: NCT00539266
Sponsor: Leiden University Medical Center
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Intermittent Claudication Peripheral Vascular Diseases

Start date: 2007-10-01
Primary completion: 2012-10-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.